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Abstract Calcium mobilization induced by phosphorylated
sphingoid bases was analyzed in calf pulmonary artery
endothelial cells by confocal microscopy. A sphingenine-1-
phosphate (SeP) analogue, N-acetyl-sphingenine-1-phosphate
(N-C2-SeP), exogenously added to these cells, caused a fast
and transient intracellular rise in calcium and was as potent as
SeP. A minimal concentration of 0.6 nM for N-C2-SeP versus 1
nM for SeP was determined. The N-C2-SeP-induced Ca2+-
signaling, like the response to SeP, was due to a release from
thapsigargin-sensitive, ryanodine-insensitive, intracellular Ca2+-
stores and not to a Ca2+-influx. N-C2-SeP can be considered as a
truncated ceramide-phosphate, a lipid already reported to be
mitogenic (Gomez-Munoz, A., Duffy, P.A., Martin, A., O’Brien,
L., Byun, H.S., Bittman, R. and Brindley, D.N. (1995) Mol.
Pharmacol. 47, 833^839), an effect that might be secondary to
Ca2+-mobilization.
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1. Introduction
Phosphorylated sphingoid bases such as sphingenine-1-
phosphate (SeP) are intermediates formed during sphingolipid
breakdown [1]. In addition, these lipids are endowed with
bioactivity and have been proposed to ful¢ll a second messen-
ger role [2,3]. In 1990, Ghosh et al. [4] observed a sphingenine-
induced Ca2-e¥ux from intracellular Ca2-stores in permea-
bilized DDT1MF-2 smooth muscle cells, that was stimulated
by ATP. This was a ¢rst indication that SeP ^ formed from
sphingenine through the action of a sphingosine kinase ^
could be involved in Ca2-signaling. Subsequently, it was
shown that externally applied SeP can induce Ca2-release
in di¡erent cell types [2,3,5]. Intracellular calcium plays an
important role in the regulation of several cellular functions
ranging from secretion, contraction, phagocytosis, cell di¡er-
entiation and proliferation to DNA synthesis and gene acti-
vation [6]. It has not been ¢rmly established how SeP causes
intracellular Ca2-release. Experimental evidence for di¡erent
mechanisms can be put forward: an interaction with G-pro-
tein coupled plasma membrane receptors [5,7] followed by a
phosphorylation/dephosphorylation cascade; a binding as a
second messenger, after uptake or intracellular generation
from sphingenine, to intracellular targets ; a stimulation,
partly modulated through G-proteins, of Ca2-entry as seen
in thyroid FRTL-5 cells [8] ; or a combination of these mech-
anisms. Data obtained in di¡erent cell types [9] indicate that
SeP can act both extracellularly as a ligand and intracellularly
as a second messenger.
In order to be considered as physiologically relevant, bind-
ing of SeP to its targets should be dependent on certain struc-
tural properties of the ligand. So far, due to di⁄culties to
obtain and synthesize analogues of SeP, not much is known
about structure-activity relationships involved in SeP-medi-
ated events. Hitherto, the speci¢city of SeP has been com-
pared mainly to that of other sphingolipids such as sphinge-
nine and sphingenine-1-phosphocholine (lysosphingomyelin,
SePC) [4,5,10^12]. These compounds and SeP are, however,
metabolically interconvertible [1], complicating the interpreta-
tion of the experimental observations. To establish a more
rigid structure-activity relationship, we started to analyze the
Ca2-release in cultured calf pulmonary artery endothelial
(CPAE) cells supplemented with di¡erent synthesized SeP
analogues as reported in a preliminary form [13]. CPAE cells
were chosen since they have been reported to be responsive to
SeP [10] and the Ca2-signaling was monitored by confocal
laser microscopy, a technique previously applied by one of us
to investigate calcium signaling in retinal pigment endothelial
cells [14]. Unexpectedly, the N-acetylated derivative of SeP
turned out to be a potent calcium mobilizing lipid.
2. Materials and methods
2.1. Cell culture and £uorescence measurements
CPAE cells were obtained from the American Type Culture Col-
lection (ATCC CCL 209, Rockville, MD, USA) and grown in Dul-
becco’s modi¢ed Eagle’s medium (Gibco-BRL), supplemented with
20% (v/v) fetal calf serum. The culture medium was replaced every
2^3 days. Cells were plated in eight-chamber Lab-Tek chambered
coverglass (Nunc) at a density of 5000 cells/cm2 and analyzed one
day after plating. Before the £uorescence analysis, cultures were in-
cubated for 30 min at 37‡C in 10 WM of £uo-3 acetoxymethyl ester
(£uo-3 AM; Molecular Probes) dissolved in Hanks’ balanced salt
solution (HBSS; Gibco-BRL) containing 1.3 mM Ca2. Subsequently,
each well was rinsed twice with HBSS, followed by addition of new
HBSS and di¡erent amounts of SeP or SeP analogues, bound to
albumin (molar lipid/albumin ratio = 1). The lipids were ¢rst dissolved
in ethanol (2 mM) and diluted with 4 volumes of HBSS containing
0.4% (w/v) defatted bovine serum albumin, before further dilution in
HBSS. Except for the addition of histamine (see further), each well
was only tested once. Fluorescence was measured with the Meridian
Insight confocal microscope (Meridian) based on an Olympus IMT2
inverted microscope with a D-plan APO100X (NA 1.25) or an S-plan
APO 60X (NA 1.4) oil-immersion objective. Ampli¢cation and collec-
tion of the £uorescence signals and further image analysis was done as
described in detail elsewhere [14]. Due to the lack of spectral shifts of
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£uo-3 £uorescence upon binding Ca2, measurements were normal-
ized to the basal £uorescence intensities after background correction
[14]. CPAE cultures were also exposed to other agonists known to
modulate calcium to obtain information about the responsiveness of
these cells and about the magnitude and time delay of their responses.
[Arg8]-vasopressin gave no or a very small Ca2-increase in these cells.
Histamine, on the other hand, gave a rapid and clear response. Hence,
histamine (10 WM ¢nal) was used as a control for cell viability and
responsiveness in our experiments. In the di¡erent experiments per-
formed, 60 to 90% of the cells present in a well were responsive to
SeP. The refractory cells did also not react to histamine.
2.2. Synthesis of lipids
SePC (lysosphingomyelin), racemic at position 3, was purchased
from Fluka Chemie (Buchs, Switzerland). Sphinganine-1-phosphate
(SaP) and 3D,L-SeP (SeP) were prepared from sphinganine-1-phos-
phocholine and SePC, respectively, by phospholipase D treatment as
described previously [15] and further puri¢ed by C18-solid phase ex-
traction [16]. N-acetyl-3D,L-sphingenine-1-phosphate (N-C2-SeP) was
obtained by acetylation of 3D,L-SeP with acetic anhydride [17].
Sphingolipid stocks were standardized by measurements of the amino
groups with trinitro-benzenesulfonic acid [18] and/or phosphate
groups, after wet ashing, by complexation with molybdate followed
by reduction with ascorbic acid [19].
3. Results and discussion
In agreement with the data reported by Meyer zu Hering-
dorf et al. [10], treatment of CPAE cells with SeP resulted in
intracellular Ca2-release. After addition of SeP in the low
nM range to these cells, loaded with £uo-3 AM, an immediate
and transient rise in the £uorescence was seen that returned to
its control value after approximately 30 s (Fig. 1A; Table 1).
Under our conditions, SeP concentrations as low as 1 nM
were e¡ective. This is comparable to the EC50 value of 0.8
nM reported by others for these cells [10] and of 2 nM for
Hek293 cells [5].
The presence of a double bond seems quite important since
SaP, a lipid identical to SeP except for the lack of the 4,5-
trans double bond, was several-fold less active than SeP (Ta-
ble 1). In our hands, SePC, tested up to 1 WM, did not cause
an intracellular Ca2-increase. Others have reported an EC50
value of 260 nM for SePC in these cells [10]. Also the response
of Hek293 cells to SePC is rather weak [5]. In DDT1MF-2
smooth muscle cells [4], MC3T3-E1 osteoblasts [12], HL60
cells [20], and Swiss 3T3 cells [21] however, an instantaneous
Ca2-release was seen after addition of SePC. Hence, the re-
sponsiveness to SePC, as to SeP, seems cell type dependent.
Rather unexpectedly, addition of N-acetylated SeP (N-C2-
SeP), an analogue that was synthesized to reveal the impor-
tance of the free amino group, resulted in a similar cellular
response as that observed with SeP, i.e. a fast and transient
change in £uorescence. A minimal concentration of 0.6 nM
was determined for N-C2-SeP (Table 1). The kinetic parame-
ters for the responses to SeP and N-C2-SeP were very similar
(Table 1; Fig. 1A). Throughout the tested range of N-C2-SeP,
the magnitude of the individual cell response was rather sim-
ilar (Fig. 1A, C).
To verify whether the N-C2-SeP-induced intracellular Ca2-
rise was due to a Ca2-in£ux, the response of CPAE cells was
analyzed in Ca2-free medium. To exclude artefacts caused by
a possible (plasma) membrane destabilization by N-C2-SeP,
these experiments were done at the maximal concentration
of lipid tested. After a preincubation of 2 min in Ca2-free
medium forti¢ed with 2 mM EGTA, a Ca2-increase was still
observed, and its magnitude appeared slightly larger than in
Ca2-containing medium at the maximal concentrations tested
(Fig. 2). This suggests that the intracellular Ca2-increase was
primarily due to a release from intracellular stores and not
caused by a Ca2-in£ux or by membrane damage. Pretreat-
ment of the cells with thapsigargin ^ a substance that depletes
the intracellular Ca2-stores by inhibiting the Ca2-ATPase
Fig. 1. E¡ect of N-C2-SeP and SeP on Ca2-mobilization in CPAE
cells. Panel A: CPAE cultures, loaded with £uo-3 AM, were stimu-
lated at time zero with 1 nM of SeP (solid thick line), 0.6 nM of
N-C2-SeP (broken line) or medium without lipid (solid thin line).
Panel B: Thapsigargin (1 WM) was added at time zero to £uo-3
AM loaded CPAE cultures to deplete the intracellular Ca2-stores.
Subsequent addition of N-C2-SeP or SeP (arrow) gave no longer an
intracellular Ca2-rise. Panel C: Fluo-3 AM loaded CPAE cultures
were preincubated for 15 min with ryanodine (10 WM) and stimu-
lated at time zero with 100 nM SeP (thick line) or 100 nM N-C2-
SeP (broken line). The recordings in panels A^C represent the re-
sponse monitored in one cell and normalized to its basal £uores-
cence as seen before addition of the lipid. The insets show the
[Ca2]i-rise, expressed in normalized £uorescence units ( þ S.D.) of n
measurements, obtained in three separate experiments, after stimula-
tion with N-C2-SeP or SeP.
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pumps of the endoplasmic reticulum [22] ^ con¢rmed this
observation. When CPAE cells were incubated with 1 WM
thapsigargin in Ca2-containing medium, the £uorescence sig-
nals increased ¢rst and declined slowly afterwards. Subse-
quent addition of N-C2-SeP or SeP gave no longer an intra-
cellular Ca2-rise (Fig. 1B). Both the inositol-1,4,5-
trisphosphate (IP3) and ryanodine receptors are involved in
the regulation of Ca2-release from intracellular Ca2-stores.
To investigate whether the N-C2-SeP-dependent Ca2-release
occurred via ryanodine-sensitive Ca2-stores, cells were prein-
cubated for 15 min with 10 WM ryanodine, followed by addi-
tion of the e¡ective lipids. A normal response was seen (Fig.
1C), suggesting that the Ca2-release is caused by an IP3-sen-
sitive or another still unknown mechanism. For SeP, the latter
possibility is more likely since heparin, an IP3 antagonist, did
not signi¢cantly alter the SeP-induced Ca2-release from mi-
crosomal vesicles prepared from DDT1MF-2 cells [23].
As far as we are aware, N-C2-SeP, a lipid that can be
considered as a ceramide-phosphate analogue, has not been
linked to Ca2-signaling. Interestingly, truncated ceramide-
phosphates (N-acetyl- and N-octanoyl-SeP) were shown to
be mitogenic for rat-1 ¢broblasts [24] and perhaps this is
caused by the Ca2-signaling we observed. Since long chain
ceramide-phosphates do not appear to a¡ect intracellular
Ca2-release, at least in Hek293 cells [5], N-acetyl-SeP (and
other truncated ceramide-phosphates) might be endowed with
a speci¢c bioactive role. Of course, it cannot be excluded that
the non-responsiveness towards long chain ceramide-phos-
phates is due to solubility problems, or that the higher po-
tency of N-C2-SeP in CPAE cells is caused by its resemblance
to lysophosphatidate or to platelet-activating factor, both bio-
active compounds that bind to speci¢c membrane receptors
[25,26]. Whether N-C2-SeP is present in biological samples has
not been investigated, but theoretically it can be formed by
acetylation of SeP, by phosphorylation of N-acetyl-sphinge-
nine, or by hydrolysis of N-acetyl-SePC. The N-acetylation of
sphingenine has recently been described [27]. Interestingly, the
transferase involved uses platelet-activating factor as acetyl-
donor, but the action of this enzyme on SeP was not inves-
tigated. The phosphorylation of N-long chain acyl-sphinge-
nine (ceramide) was reported in HL60 cells [28] and in human
neutrophils [29]. It has also not been established at which
cellular site N-C2-SeP (and SeP) is interacting, either at the
plasma membrane or at the endoplasmic reticulum. During
the course of our experiments, di¡erent approaches have pro-
vided evidence for the existence of multiple plasma membrane
lysophospholipid receptors. van Koppen and coworkers
showed that the response of a number of di¡erentiated cell
types to SeP and SePC and other lysosphingolipids varies
considerably and postulates the presence of three types of
receptors that interact with SeP and/or other lysosphingolipids
[3,5]. By resemblance to the lysophosphatidate receptor, a
number of other receptors that display speci¢city towards
SeP such as edg1 [30], edg3 [31], and H218 [31] was recently
cloned. Obviously, these are likely candidates for binding N-
acetyl-SeP as well. On the other hand, Mao et al. [32] discov-
ered a SePC-gated Ca2-channel, likely localized to the endo-
plasmic reticulum. Not much is known about the uptake and
membrane translocation of phosphorylated sphingoid bases.
Studies with labeled SeP [33] or SaP [34] indicate that these
compounds, despite their charges, can cross the plasma mem-
brane. The higher potency of N-C2-SeP, lacking the positive
charge, could therefore be as well caused by a better uptake,
followed by binding, with or without a deacylation step, to its
intracellular target.
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